Browse the evidence

Current hypertension guidelines do not yet recommend incretin-based therapies as first-line treatment because no large-scale trial has used blood pressure reduction as its primary endpoint, despite robust secondary data showing efficacy.

You cannot currently get GLP-1 medications prescribed specifically for high blood pressure as a first-line treatment under standard insurance guidelines. They are primarily approved for diabetes and weight loss. However, if you have both hypertension and obesity/diabetes, your doctor may prescribe them for those conditions, which will incidentally lower your blood pressure significantly.

Genetic variants (SNPs) associated with obesity, diabetes, and cardiovascular disease generally have small effect sizes and explain a small fraction of the overall variance in these conditions.

Understanding your genetics does not give you a free pass or a guaranteed outcome. Most genetic risks are small and can be managed. Focus on modifiable risk factors like BMI, blood pressure, and diet quality.

Implementation of Enhanced Recovery After Surgery (ERAS) protocols in bariatric surgery significantly reduces postoperative nausea and vomiting, intraoperative time, time to mobilization, intensive care unit stay, and total/functional hospital stay compared to standard care, without increasing complication rates.

For bariatric surgery units, adopting ERAS protocols is a high-value intervention. It significantly reduces patient suffering (nausea/vomiting), shortens hospital stays, and speeds up mobilization without increasing surgical risks like leaks or bleeding. Implementation should be prioritized where feasible.

Cardiovascular-Kidney-Metabolic (CKM) syndrome is a systemic disorder characterized by pathophysiological interactions among metabolic risk factors, chronic kidney disease (CKD), and the cardiovascular system, leading to multiorgan dysfunction and high adverse outcome rates.

If you have high blood pressure, diabetes, or kidney issues, recognize that these conditions are linked and worsen each other. Managing one without addressing the others is less effective. Seek integrated care that looks at your heart, kidneys, and metabolic health together to prevent serious complications like heart failure or kidney failure.

Chronic Kidney Disease (CKD) significantly amplifies cardiovascular risk, with albuminuria and low GFR being strong predictors of major atherosclerotic and heart failure events, often making CVD the leading cause of death in CKD patients.

If you have kidney disease, your risk of heart problems is significantly higher. Regular monitoring of your heart health, along with managing blood pressure and blood sugar, is essential to prevent heart failure and heart attacks.

Obesity is not caused by a lack of willpower but is the result of complex interactions between individual biological factors and environmental determinants, requiring multifactorial prevention and treatment strategies.

Stop blaming yourself for your weight. Obesity is a complex disease influenced by biology and your environment, not just willpower. Effective management requires addressing both individual health behaviors and the broader environment, such as access to healthy food and safe spaces for activity.

Environmental-level factors, such as the food environment and socioeconomic status, interact with individual-level biological factors to drive obesity, and interventions focusing solely on the individual are suboptimal.

To manage weight effectively, you need to address both your personal habits and your environment. This might mean seeking out healthier food options, advocating for policy changes, and understanding how your biology interacts with your surroundings.

BMI is an insufficient diagnostic tool for obesity because it fails to differentiate between fat mass and lean body mass, leading to misclassification.

Do not rely solely on BMI to determine your health status. It fails to distinguish between muscle and fat. Ask your doctor for more precise assessments like waist circumference or body composition analysis to get a true picture of your metabolic risk.

Heart disease and stroke remain the leading causes of death globally, with significant disparities in prevalence and mortality across different racial and ethnic groups, necessitating targeted public health interventions to address structural racism and health equity.

Focus on managing key risk factors like blood pressure, cholesterol, and blood sugar, while being aware of and addressing potential systemic barriers to healthcare access.

Chronic low-grade inflammation (inflammaging) is a fundamental endogenous driver of aging, creating a vicious cycle with cellular senescence that leads to organ dysfunction and age-related diseases.

Aging is closely linked to chronic, low-grade inflammation. While this paper is a mechanistic review, the implication is that strategies reducing systemic inflammation may support healthy aging. Focus on lifestyle factors known to modulate inflammation, such as regular physical activity, adequate sleep, and a nutrient-dense diet, as these are foundational to managing 'inflammaging'.

Immunosenescence, characterized by a decline in immune cell function and an increase in pro-inflammatory cytokine secretion, impairs the clearance of senescent cells and pathogens, exacerbating aging.

Immune function declines with age, leading to increased susceptibility to infection and chronic inflammation. Maintaining immune health through vaccination, stress management, and nutrient adequacy is crucial for older adults.

Accelerated biological aging of specific organs, measured via plasma proteomic signatures, significantly increases the risk of organ-specific diseases and all-cause mortality, independent of chronological age.

Your chronological age is not your biological destiny. This research shows that your organs age at different rates, and accelerated aging in specific organs (like the heart or brain) is a strong predictor of future disease and mortality, independent of how many birthdays you've had. While this specific test is not yet standard care, the key takeaway is that organ-specific health monitoring is crucial. Focus on maintaining the health of your most vulnerable organs through targeted lifestyle interventions, as organ-specific aging is a modifiable risk factor for major diseases like heart failure and Alzheimer's.

Chronic low-grade inflammation (inflammaging) acts as a bidirectional driver that exacerbates all other hallmarks of aging, creating a vicious cycle that accelerates biological aging and age-related diseases.

Chronic, low-grade inflammation is a central accelerator of aging. While not an intervention itself, understanding 'inflammaging' highlights the importance of lifestyle factors (diet, exercise) that modulate immune response and reduce this persistent inflammatory state, thereby potentially slowing the progression of age-related diseases.

Epigenetic aging, as measured by the Skin&blood clock, is distinct from cellular senescence, telomere attrition, and genomic instability, but is associated with nutrient sensing, mitochondrial activity, and stem cell composition.

Epigenetic age is not a simple proxy for cellular damage or telomere length. Interventions that extend lifespan (like caloric restriction or rapamycin) slow epigenetic aging, while those that extend lifespan via other mechanisms (like NAD precursors or metformin in this specific context) may not. To influence epigenetic age, focus on nutrient sensing (mTOR pathway) and mitochondrial health, as these are mechanistically linked to the clock's ticking, distinct from DNA repair or telomere maintenance.

Consumer-grade wearable devices are not exempt from rigorous performance evaluation simply because they are marketed as 'research' or 'clinical' grade, as proprietary algorithms and hardware inconsistencies can still lead to significant errors.

Do not assume a device is accurate because it is 'clinical grade' or 'FDA cleared'. You must validate the specific device's sleep staging accuracy against PSG for your specific study population before using it for research conclusions.

Current food environment policies in Vietnam are insufficient, with 74% of assessed indicators scoring low or very low, particularly in food composition standards, marketing, and labeling.

Policymakers must move beyond food safety regulations to address nutritional quality. This requires implementing mandatory food composition standards (e.g., sugar/salt/trans-fat limits), restricting marketing of unhealthy foods (especially to children), and enforcing front-of-package labeling.

SGLT2 inhibitors significantly reduce the risk of hospitalization for heart failure and cardiovascular death in patients with type 2 diabetes, regardless of baseline glycemic control or heart failure status.

If you have Type 2 Diabetes and Heart Failure (or high risk for it), ask your doctor about SGLT2 inhibitors (like Jardiance or Farxiga). These drugs have strong evidence for reducing hospitalizations for heart failure and cardiovascular death, independent of their blood sugar-lowering effects. They are now a standard part of heart failure treatment guidelines.

Bariatric surgery remains the most effective long-term treatment for severe obesity, offering superior durability and comorbidity remission compared to pharmacotherapy.

For severe obesity, surgery is still the most durable and effective option for long-term health improvement. It offers better comorbidity remission than drugs alone. Consider it if your BMI is very high or you have serious health issues.

Roux-en-Y Gastric Bypass (RYGB) and Sleeve Gastrectomy (SG) are highly effective surgical interventions for severe obesity, with RYGB showing slightly greater long-term weight loss.

Surgical options like RYGB and SG are highly effective for severe obesity, leading to 47-55% excess weight loss over seven years. RYGB tends to result in slightly greater weight loss than SG, but both improve quality of life. These are major surgeries requiring careful patient selection and postoperative management.

Fasting is defined as voluntary abstinence from some or all foods or beverages for preventive, therapeutic, religious, cultural, or other reasons, distinguishing it from starvation which is involuntary and pathological.

To fast, you voluntarily abstain from food and/or beverages for a specific period. This is distinct from starvation, which is involuntary and harmful. Your motivation (health, religion, culture) defines the context, but the core action is voluntary abstinence.

Absolute variance statistics (SDir, lnVR) are insufficient for detecting true interindividual response variation because they are confounded by mean-variance relationships (where higher means lead to higher variances); the Log Ratio of Coefficient of Variation (lnCVR) is required to isolate true response heterogeneity.

When evaluating resistance training results, do not assume that a wider range of outcomes (some people growing a lot, some a little) is solely due to individual 'trainability.' It may simply be that those who grew more had higher starting strengths, which naturally scale with greater variance. To truly understand why some people don't respond, you must look at relative variation (coefficient of variation) rather than absolute changes. For the individual, this means that 'average' program prescriptions will inevitably fail some people, not because the program is bad, but because biological scaling laws dictate that larger gains come with larger variance.

2'-FL supplementation does NOT significantly alter the Cytokine Response Score (CRS), a marker of immune aging, in older adults, despite increasing Bifidobacterium.

Taking 2'-FL (1g or 5g daily) for 6 weeks did not improve the Cytokine Response Score, a marker of immune aging, in older adults. However, it did increase Bifidobacterium and HDL cholesterol. Users should not expect this to reverse immune aging markers based on this study.

There is a significant disconnect between mechanistic research (e.g., mTOR signaling) and applied intervention studies, leading to a lack of systematic translation of basic science into concrete intervention strategies.

Current research often fails to bridge the gap between molecular science and practical advice. For now, focus on the proven basics: consistent resistance training and adequate protein intake, rather than trying to optimize based on complex molecular mechanisms that haven't been fully translated into practical protocols.

Particulate matter air pollution is the leading contributor to global disease burden, accounting for 8.0% of total DALYs in 2021.

Air pollution is the leading risk factor for global disease burden. Reducing exposure is crucial for long-term health.